Related Experiment Video
Updated: Jun 25, 2026

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
Published on: September 27, 2024
Transitions to and reversion from a persistent frequent-exacerbator state in COPD
Delphine Vauterin1, Frauke Van Vaerenbergh1, Lowie E G W Vanfleteren2,3,4
1Department of Bioanalysis, Ghent University, Ghent, Belgium.
Background:
Preventing acute exacerbations in COPD (AECOPDs) is key in striving for disease stability. To investigate the differential impact of risk factors across AECOPD phenotypes, we identified baseline health determinants and comorbidities associated with transitions from non-exacerbator (NE) to persistent frequent-exacerbator (FE) and reversion.
Methods:
Patients ≥45 years with ≥3 months treatment for obstructive airway diseases or hospital-labelled COPD without (concomitant) asthma were identified in Belgian nationwide data between January 2017-February 2018. Factors associated with disease worsening (transitioning from NE to persistent FE), reversion (from FE to stable NE) or transition to death were investigated using multinomial logistic regression.
Results:
Among 183 762 patients (mean age 68.6 years, 48.0% female), 11.5% (21 072) never experienced AECOPDs and 11.6% (21 375) exacerbated frequently in each of three consecutive years. Among 56 933 NE at baseline (31.0%), 4.1% transitioned to persistent FE, whereas among 80 502 FE (43.8%), 7.3% reversed to stable NE. Transitions from NE towards persistent FE were associated with having lung cancer (adjusted odds ratio (aOR) 3.67, 95% CI 2.33-5.78), being an ever-smoker (aOR 2.09, 95% CI 1.94-2.43) or having neuropsychiatric or musculoskeletal comorbidity. Overuse of short-acting bronchodilators (aOR 0.57, 95% CI 0.46-0.49), ever-smoking or having overuse of maintenance therapy were factors most strongly associated with lower odds of reversion. Cardiovascular comorbidities were significantly associated with increased mortality odds, but not with disease worsening.
Conclusions:
The results of this cohort study support addressing smoking and inhaler overuse to promote reversion to stable NE, while managing lung cancer and neuropsychiatric or musculoskeletal comorbidities to reduce worsening.
Related Concept Videos
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-I: Introduction